AHL Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

AHL Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$4.78M	Buy	45,604 +1,093	+2%	+$120K	0.07%	501
2017 Q3	$5.02M	Buy	44,511 +17,907	+67%	+$1.95M	0.09%	399
2017 Q2	$2.98M	Buy	26,604 +6,923	+35%	+$782K	0.06%	522
2017 Q1	$2.3M	Sell	19,681 -889	-4%	-$98.4K	0.05%	596
2016 Q4	$2.17M	Buy	20,570 +7,348	+56%	+$770K	0.07%	487
2016 Q3	$1.46M	Buy	13,222 +6,389	+94%	+$846K	0.05%	481
2016 Q2	$995K	Buy	6,833 +1,681	+33%	+$238K	0.05%	446
2016 Q1	$738K	Sell	5,152 -13,641	-73%	-$1.94M	0.05%	468
2015 Q4	$2.9M	Buy	18,793 +15,189	+421%	+$2.22M	0.22%	156
2015 Q3	$515K	Sell	3,604 -32,233	-90%	-$4.51M	0.08%	364
2015 Q2	$5.15M	Sell	35,837 -3,344	-9%	-$477K	0.21%	167
2015 Q1	$5.53M	Buy	39,181 +20,401	+109%	+$3.14M	0.22%	130
2014 Q4	$2.78M	Buy	+18,780	New	+$2.76M	0.14%	276

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

AHL Partners's TARO Position: Q4 2017 in Review

AHL Partners increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 2.5% in Q4 2017, buying an estimated $120K and bringing the position to 45,604 shares worth $4.78M. The position accounts for 0.07% of the portfolio, ranked #501.

AHL Partners first reported a position in TARO in Q4 2014 and has held it in 13 quarters since. The position peaked at $5.53M in Q1 2015. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

AHL Partners held 45,604 shares of Taro Pharmaceutical Industries Ltd. worth $4.78M as of Q4 2017.
AHL Partners bought 1,093 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $120K.
Taro Pharmaceutical Industries Ltd. made up 0.07% of AHL Partners's portfolio in Q4 2017, its #501 holding.
AHL Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and has held it in 13 quarters since.
AHL Partners's Taro Pharmaceutical Industries Ltd. position peaked at $5.53M in Q1 2015.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.